DK200301128A - Tilskudspræparat - Google Patents

Tilskudspræparat Download PDF

Info

Publication number
DK200301128A
DK200301128A DK200301128A DKPA200301128A DK200301128A DK 200301128 A DK200301128 A DK 200301128A DK 200301128 A DK200301128 A DK 200301128A DK PA200301128 A DKPA200301128 A DK PA200301128A DK 200301128 A DK200301128 A DK 200301128A
Authority
DK
Denmark
Prior art keywords
active component
composition according
silver
preparation
cartilage
Prior art date
Application number
DK200301128A
Other languages
English (en)
Inventor
Thomsen Joern Oddershede
Original Assignee
Thomsen Joern Oddershede
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomsen Joern Oddershede filed Critical Thomsen Joern Oddershede
Priority to DK200301128A priority Critical patent/DK200301128A/da
Priority to OA1200600039A priority patent/OA13229A/en
Priority to AU2004260578A priority patent/AU2004260578B2/en
Priority to JP2006522234A priority patent/JP2007501006A/ja
Priority to CNB200480022356XA priority patent/CN100444744C/zh
Priority to DE602004018149T priority patent/DE602004018149D1/de
Priority to EA200600365A priority patent/EA011386B1/ru
Priority to AP2003001128A priority patent/AP2006003501A0/xx
Priority to UAA200602386A priority patent/UA85060C2/ru
Priority to AP2006003501A priority patent/AP2031A/xx
Priority to DK04739018T priority patent/DK1651061T3/da
Priority to US10/566,729 priority patent/US7655260B2/en
Priority to PCT/DK2004/000521 priority patent/WO2005011400A1/en
Priority to AT04739018T priority patent/ATE415825T1/de
Priority to CA002532883A priority patent/CA2532883A1/en
Priority to EP04739018A priority patent/EP1651061B1/en
Publication of DK200301128A publication Critical patent/DK200301128A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/20—Animal feeding-stuffs from material of animal origin
    • A23K10/22—Animal feeding-stuffs from material of animal origin from fish
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)

Description

Patentkrav 1. Tilskudspræparat omfattende a) en første aktiv komponent i form af biologisk tilgængeligt sølv, og b) en anden aktiv komponent i form at et materiale, som er udvundet fra brusk, samt eventuelle konventionelle hjælpe- eller tilsætningsstoffer. 2. Præparat ifølge krav 1, kendetegnet ved, at det omfatter en eller flere yderlige¬ re aktive komponenter. 3. Præparat ifølge krav 2, kendetegnet ved, at det omfatter c) en tredje aktiv komponent omfattende antimonpentasulfid og tinjodid. 4. Præparat ifølge krav 2, kendetegnet ved, at det omfatter d) en fjerde aktiv komponent omfattende metallisk zink eller et zinksalt. 5. Præparat ifølge krav 1, kendetegnet ved, at den første aktive komponent (a) er kolloidt sølv. 6. Præparat ifølge krav 1, kendetegnet ved, at den anden aktive komponent (b) er udvundet af brusk fra en bruskfisk, fortrinsvis fra en haj. 7. Præparat ifølge krav 1, kendetegnet ved, at indholdet af bruskmateriale, regnet som tørstof, er på 100 - 12.000 vægtdele pr. 1 vægtdel biologisk tilgængeligt sølv, for¬ trinsvis 200 - 6000 vægtdele pr. 1 vægtdel biologisk tilgængeligt sølv, og særligt fore¬ trukket 300 - 3000 vægtdele pr. 1 vægtdel biologisk tilgængeligt sølv. 8. Præparat ifølge et hvilket som helst af de foregående krav, kendetegnet ved, at det indeholder 0,5 - 50 mg biologisk tilgængeligt sølv pr. liter præparat, fortrinsvis 1 - 20 mg sølv pr. liter. 9. Anvendelse af (a) en første aktiv komponent i form af biologisk tilgængeligt sølv, og (b) en anden aktiv komponent i form at et materiale, som er udvundet fra brusk, samt eventuelle yderligere aktive komponenter og/eller konventionelle hjælpe¬ eller tilsætningsstoffer til fremstilling af et sundhedsfremmende tilskudspræparat til husdyr. 10. Anvendelse ifølge krav 9 af (a) en første aktiv komponent i form af biologisk tilgængeligt sølv, og (b) en anden aktiv komponent i form at et materiale, som er udvundet fra brusk, samt eventuelle yderligere aktive komponenter og/eller konventionelle hjælpe- eller tilsætningsstoffer til fremstilling af et præparat til forebyggelse mod og behandling af plasmacytose, hvalpesyge, virus enteritis, 3-dages syge og/eller fedtede hvalpe hos mink.
DK200301128A 2003-08-05 2003-08-05 Tilskudspræparat DK200301128A (da)

Priority Applications (16)

Application Number Priority Date Filing Date Title
DK200301128A DK200301128A (da) 2003-08-05 2003-08-05 Tilskudspræparat
OA1200600039A OA13229A (en) 2003-08-05 2004-08-02 Supplement preparation.
AU2004260578A AU2004260578B2 (en) 2003-08-05 2004-08-02 Supplement preparation
JP2006522234A JP2007501006A (ja) 2003-08-05 2004-08-02 サプリメント製剤
CNB200480022356XA CN100444744C (zh) 2003-08-05 2004-08-02 增补制剂
DE602004018149T DE602004018149D1 (de) 2003-08-05 2004-08-02 Ergänzungszusammensetzung mit knorpel und silber
EA200600365A EA011386B1 (ru) 2003-08-05 2004-08-02 Биологически активная пищевая добавка для людей и животных
AP2003001128A AP2006003501A0 (en) 2003-08-05 2004-08-02 Supplement preparation.
UAA200602386A UA85060C2 (ru) 2003-08-05 2004-08-02 Биологически активная добавка к пище
AP2006003501A AP2031A (en) 2003-08-05 2004-08-02 Supplement preparation
DK04739018T DK1651061T3 (da) 2003-08-05 2004-08-02 Tilskudspræparat indeholdende brusk og sölv
US10/566,729 US7655260B2 (en) 2003-08-05 2004-08-02 Supplement preparation
PCT/DK2004/000521 WO2005011400A1 (en) 2003-08-05 2004-08-02 Supplement preparation
AT04739018T ATE415825T1 (de) 2003-08-05 2004-08-02 Ergänzungszusammensetzung mit knorpel und silber
CA002532883A CA2532883A1 (en) 2003-08-05 2004-08-02 Supplement preparation
EP04739018A EP1651061B1 (en) 2003-08-05 2004-08-02 Supplement preparation containing cartilage and silver

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK200301128A DK200301128A (da) 2003-08-05 2003-08-05 Tilskudspræparat

Publications (1)

Publication Number Publication Date
DK200301128A true DK200301128A (da) 2005-02-06

Family

ID=34112403

Family Applications (2)

Application Number Title Priority Date Filing Date
DK200301128A DK200301128A (da) 2003-08-05 2003-08-05 Tilskudspræparat
DK04739018T DK1651061T3 (da) 2003-08-05 2004-08-02 Tilskudspræparat indeholdende brusk og sölv

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK04739018T DK1651061T3 (da) 2003-08-05 2004-08-02 Tilskudspræparat indeholdende brusk og sölv

Country Status (14)

Country Link
US (1) US7655260B2 (da)
EP (1) EP1651061B1 (da)
JP (1) JP2007501006A (da)
CN (1) CN100444744C (da)
AP (2) AP2006003501A0 (da)
AT (1) ATE415825T1 (da)
AU (1) AU2004260578B2 (da)
CA (1) CA2532883A1 (da)
DE (1) DE602004018149D1 (da)
DK (2) DK200301128A (da)
EA (1) EA011386B1 (da)
OA (1) OA13229A (da)
UA (1) UA85060C2 (da)
WO (1) WO2005011400A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202008014500U1 (de) * 2008-10-31 2009-01-22 Schreiber, Monika Christine Futtermittel für Tiere
RU2425587C1 (ru) * 2009-12-24 2011-08-10 Сергей Иванович Першин Кормовой продукт для продуктивных сельскохозяйственных животных и птиц

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746504A (en) 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
FR2618677B1 (fr) * 1987-07-31 1989-12-22 Besnouin Didier Composition pharmaceutique destinee a la prevention et au traitement des maladies bacteriennes ou virales
JPH0341774U (da) * 1989-09-04 1991-04-22
IT1243435B (it) * 1990-10-05 1994-06-10 Altergon Sa Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti
JP3422762B2 (ja) * 1992-05-08 2003-06-30 松下電器産業株式会社 悪臭抑制ペットフード
JP3159772B2 (ja) * 1992-05-08 2001-04-23 松下電器産業株式会社 抗菌性ワックス
AU5596494A (en) 1992-11-30 1994-06-22 I. William Lane Processing shark cartilage
RU2087148C1 (ru) * 1993-06-24 1997-08-20 Василий Васильевич Третьяков Способ лечения острых вирусных заболеваний животных семейства псовых
US6017901A (en) 1995-05-10 2000-01-25 Fidia Advanced Bioplymers S.R.L. Heavy metal salts of succinic acid hemiesters with hyaluronic acid or hyaluronic acid esters, a process for their preparation and relative pharmaceutical compositions
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
AUPO920597A0 (en) * 1997-09-16 1997-10-09 Micronized Foods Pty Ltd Pharmaceutical and/or therapeutic composition or preparation comprising shark cartilage and emu oil
JP4039719B2 (ja) * 1997-10-17 2008-01-30 富士フイルム株式会社 抗腫瘍剤
BR9915174A (pt) * 1998-11-09 2001-11-06 Ira Jay Newman Complexo de prata iÈnica
JP2000309537A (ja) * 1999-04-28 2000-11-07 Seikagaku Kogyo Co Ltd 腸疾患予防及び／または治療剤
WO2001076650A1 (en) * 2000-04-06 2001-10-18 University Technology Corporation Compositions and methods for promoting wound healing
JP2002145794A (ja) 2000-08-31 2002-05-22 Nippon Kayaku Co Ltd 抗関節炎もしくは抗リュウマチ製剤、食品又は飼料
EP1356811B1 (en) 2001-01-05 2007-02-21 Kyowa Hakko Kogyo Co., Ltd. Combination of three substances for the prevention or treatment of arthritis
US6528040B1 (en) * 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
CA2445734A1 (en) * 2001-04-23 2002-10-31 Nucryst Pharmaceuticals Corp. Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
KR20030018700A (ko) * 2001-08-31 2003-03-06 김인달 질석을 담체로 하여 은을 결합한 살균제 및 그 사용방법
JP2003073403A (ja) * 2001-08-31 2003-03-12 Takara Bio Inc ムコ多糖及び／又はコラーゲン
DE60212542T2 (de) 2001-10-12 2007-06-21 Nipro Corp., Osaka Injektionslösung enthaltend ein Kolloid aus Eisen und Haiknorpel-Chondroitinsulfat

Also Published As

Publication number Publication date
US20060246147A1 (en) 2006-11-02
AU2004260578B2 (en) 2010-07-29
CA2532883A1 (en) 2005-02-10
JP2007501006A (ja) 2007-01-25
US7655260B2 (en) 2010-02-02
CN1842276A (zh) 2006-10-04
AP2006003501A0 (en) 2006-02-28
UA85060C2 (ru) 2008-12-25
EP1651061B1 (en) 2008-12-03
EA200600365A1 (ru) 2006-06-30
ATE415825T1 (de) 2008-12-15
EP1651061A1 (en) 2006-05-03
OA13229A (en) 2006-12-13
AP2031A (en) 2009-08-24
EA011386B1 (ru) 2009-02-27
DK1651061T3 (da) 2009-03-30
AU2004260578A1 (en) 2005-02-10
WO2005011400A1 (en) 2005-02-10
DE602004018149D1 (de) 2009-01-15
CN100444744C (zh) 2008-12-24

Similar Documents

Publication Publication Date Title
Lewis Feeding and care of the horse
Hansel et al. Use of diagnostic bones to identify and estimate original lengths of ingested prey fishes
Chowdhury et al. Gastrointestinal uptake and fate of cadmium in rainbow trout acclimated to sublethal dietary cadmium
Alves et al. The chronic effects of dietary lead in freshwater juvenile rainbow trout (Oncorhynchus mykiss) fed elevated calcium diets
Thom et al. Why are American mink sexually dimorphic? A role for niche separation
WO2011078677A3 (en) Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
JP2009073853A (ja) Ｐｄｅ−抑制物質とアデニル酸シクラーゼ・アゴニストもしくはグアニル酸シクラーゼ・アゴニストとからなる相乗的組み合わせ組成物
WO2005051396A3 (en) Methods for reducing body fat using vitamin d compounds
CN101795685A (zh) 羟脯氨酸组合物及其用途
ES2431085T3 (es) Uso de glutamato, derivados o metabolitos de glutamato, análogos de glutamato o mezclas de los mismos para la fabricación de una composición para el tratamiento de osteoporosis
BR0316365A (pt) Redutor de aumento do nìvel de glicose no sangue, redutor de acúmulo de gordura no corpo e material alimentìcio
Kamunde et al. Environmental chemistry, physiological homeostasis, toxicology, and environmental regulation of copper, an essential element in freshwater fish
DK200301128A (da) Tilskudspræparat
JP2002145765A5 (da)
Rahmani The effect of reducing calcium and phosphorous on broiler performance
JP2007515402A5 (da)
JP2005510257A5 (da)
JP2003335698A (ja) 高尿酸血症治療又は予防用組成物
JP3742910B2 (ja) イノシトール高濃度含有卵並びに飼料
JP2005047851A5 (da)
Brenner Chronic renal failure: a disorder of adaptation
JP2004189685A (ja) 機能性経口組成物
Salesa et al. New insights on the ecology and behavior of Machairodus aphanistus (Carnivora, Felidae, Machairodontinae) through the paleopathological study of the fossil sample from the Late Miocene (Vallesian, MN 10) of Cerro de los Batallones (Torrejón de Velasco, Madrid, Spain)
Ulemale et al. Fluorosis in cattle
Kjoss et al. Dietary Na does not reduce dietary Cu uptake by juvenile rainbow trout

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment